​Bio Medical Beauty Group Ultra V (CEO Hanjin Kwon) attended the International Aesthetic Plastic Surgery Conference 'IMCAS PARIS 2024 (International Master Course on Aging Science World Congress 2024) held at the Palais des Congrès in Paris, France from February 1 to 3. ' and introduced the excellence of 'UltraCol'.

​

This exhibition, which celebrates its 25th anniversary this year, is the world's largest academic conference with more than 14,000 dermatologists and plastic surgeons from around the world participating, and is a place where professional knowledge, including technology in the beauty field, is actively shared.

At IMCAS 2024, Ultra V showcased its full range of products, from PDO and PCL absorbable threads with unique technology, which were its main exports, to the Idebenon cosmetics line, and medical equipment Triderm, Hifu Plus, Colasti, etc., have received European CE certification.

Ultra V introduced its differentiated technologies and devices to the many visitors attending this expo and welcomed domestic and foreign buyers. ‘UltraCol’ which received approval in many countries around the world, including Asia, South America, the Middle East, and Europe, and received certification in the global market, elicited a positive response from local buyers.

Dr. Kwon, Ultra V CEO, gave a lecture on ‘UltraCol’, shared her own clinical data, know-how, and knowledge through various clinical cases, and had time to experience the special benefits of ‘UltraCol’. The high response from medical staff around the world continued, confirming the high interest in ‘UltraCol’ from global users, solidifying its position in the global market.

CEO Kwon Hanjin expressed his ambition, saying, “As the filler, botox, and threads markets have recently grown rapidly in the global market, and at the same time the need for the latest aesthetic medical procedures has increased, we plan to strengthen our activities to communicate directly with local customers.”

UltraCol is the first microsphere-based bio stimulator and skin booster made from FDA-registered polydioxanone (PDO) ingredients, which uses the body's immune response to stimulate autologous collagen to help with the face’s volume, lifting, and elasticity. In particular, after the treatment, it is broken down and absorbed by the body, without any adverse reactions or side effects, and no need to remove it. Recognized for its technological prowess, it has obtained approval from the Korean Ministry of Food and Drug Safety (KFDA) and European CE certification and has a history of winning the IR52 Jang Young-shil Award and the Korea Patent Grand Prize for its unrivaled patented technology.

Meanwhile, following Hong Kong last year, Ultra V received product approval in Italy, Thailand, Ecuador, Kuwait, the Philippines, and Hainan, and recently completed obtaining product approval in Malaysia. As a result, Ultra V has dealers and registrations in more than 30 countries, and plan to expand our reach globally in the future.​